Rabia Gurses Ozden serves as Executive at OCULAR THERAPEUTIX, INC, where they oversee executive responsibilities. Since joining the company, Rabia Gurses Ozden has executed 10 insider transactions totaling $100.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 9, 2025 involved transacting 8,125 shares valued at $0.
Rabia Gurses Ozden currently holds 85,000 shares of OCULAR THERAPEUTIX, INC (OCUL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rabia Gurses Ozden has been a net seller of OCUL stock. They have purchased $0 and sold $100.6K worth of shares.
Rabia Gurses Ozden's most recent insider trade was on Dec 9, 2025, when they sold 8,125 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 9, 2025 | ADVM | $0 | Tender | 85,000 | $N/A | Discretionary |
| Feb 5, 2024 | OCUL | $30.8K | Sale | 6,346 | $4.86 | Discretionary |
| Feb 3, 2024 | OCUL | $0 | Award | 66,633 | $N/A | Discretionary |
| Jan 31, 2024 | OCUL | $38.4K | Sale | 7,764 | $4.95 | Discretionary |
| Jul 7, 2023 | OCUL | $4.1K | Sale | 832 | $4.93 | Discretionary |
| Feb 6, 2023 | OCUL | $27.2K | Sale | 6,416 | $4.24 | Discretionary |
| Jan 30, 2023 | OCUL | $0 | Award | 55,556 | $N/A | Discretionary |
| Jul 1, 2022 | OCUL | $0 | Award | 6,667 | $N/A | Discretionary |